The application of a stable Adgrg6‐activating PrP‐based molecule failed to rescue a peripheral demyelinating neuropathy in PrP knock‐out mice, and transcriptomic data suggested that the rescuing agent might itself be myotoxic (Henzi et al., 2020). This evidence concerns the gene PRNP and demyelinating polyneuropathy.